BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 32129665)

  • 1. NADPH Oxidase Inhibition in Fibrotic Pathologies.
    Bernard K; Thannickal VJ
    Antioxid Redox Signal; 2020 Aug; 33(6):455-479. PubMed ID: 32129665
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Neurodegenerative Diseases: Mechanisms and Therapy.
    Hou L; Zhang L; Hong JS; Zhang D; Zhao J; Wang Q
    Antioxid Redox Signal; 2020 Aug; 33(5):374-393. PubMed ID: 31968994
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibiting the Activity of NADPH Oxidase in Cancer.
    Konaté MM; Antony S; Doroshow JH
    Antioxid Redox Signal; 2020 Aug; 33(6):435-454. PubMed ID: 32008376
    [No Abstract]   [Full Text] [Related]  

  • 4. NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents.
    Babalola O; Mamalis A; Lev-Tov H; Jagdeo J
    Arch Dermatol Res; 2014 May; 306(4):313-330. PubMed ID: 24155025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications.
    Urner S; Ho F; Jha JC; Ziegler D; Jandeleit-Dahm K
    Antioxid Redox Signal; 2020 Aug; 33(6):415-434. PubMed ID: 32008354
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of NADPH oxidase research in cardiovascular pharmacology.
    Rodiño-Janeiro BK; Paradela-Dobarro B; Castiñeiras-Landeira MI; Raposeiras-Roubín S; González-Juanatey JR; Alvarez E
    Vasc Health Risk Manag; 2013; 9():401-28. PubMed ID: 23983473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NADPH Oxidase Family and Its Inhibitors.
    Chocry M; Leloup L
    Antioxid Redox Signal; 2020 Aug; 33(5):332-353. PubMed ID: 31826639
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of NADPH oxidases in the redox biology of liver fibrosis.
    Crosas-Molist E; Fabregat I
    Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.
    Mortezaee K
    Cell Biochem Funct; 2018 Aug; 36(6):292-302. PubMed ID: 30028028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
    Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
    Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting NOX enzymes in pulmonary fibrosis.
    Hecker L; Cheng J; Thannickal VJ
    Cell Mol Life Sci; 2012 Jul; 69(14):2365-71. PubMed ID: 22618245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights of NADPH oxidases and its pathological consequences.
    Waghela BN; Vaidya FU; Agrawal Y; Santra MK; Mishra V; Pathak C
    Cell Biochem Funct; 2021 Mar; 39(2):218-234. PubMed ID: 32975319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NADPH oxidases in liver fibrosis.
    Paik YH; Kim J; Aoyama T; De Minicis S; Bataller R; Brenner DA
    Antioxid Redox Signal; 2014 Jun; 20(17):2854-72. PubMed ID: 24040957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.
    Altenhöfer S; Radermacher KA; Kleikers PW; Wingler K; Schmidt HH
    Antioxid Redox Signal; 2015 Aug; 23(5):406-27. PubMed ID: 24383718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses.
    Jiang F; Liu GS; Dusting GJ; Chan EC
    Redox Biol; 2014; 2():267-72. PubMed ID: 24494202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities.
    Peshavariya H
    Curr Pharm Des; 2015; 21(41):5931-2. PubMed ID: 26537745
    [No Abstract]   [Full Text] [Related]  

  • 17. NADPH oxidases and inflammatory bowel disease.
    Lam G; Apostolopoulos V; Zulli A; Nurgali K
    Curr Med Chem; 2015; 22(17):2100-9. PubMed ID: 25876884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease.
    Sampson N; Berger P; Zenzmaier C
    Biomed Res Int; 2014; 2014():131737. PubMed ID: 24701562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
    Altenhöfer S; Kleikers PW; Radermacher KA; Scheurer P; Rob Hermans JJ; Schiffers P; Ho H; Wingler K; Schmidt HH
    Cell Mol Life Sci; 2012 Jul; 69(14):2327-43. PubMed ID: 22648375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual Role of Reactive Oxygen Species-Generating Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Gastrointestinal Inflammation and Therapeutic Perspectives.
    Dang PM; Rolas L; El-Benna J
    Antioxid Redox Signal; 2020 Aug; 33(5):354-373. PubMed ID: 31968991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.